Dr. Joseph J. Carter

Fred Hutchinson Cancer Research Center




Ph.D., Biochemistry, Washington State University, USA

B.S., Chemistry, Lewis and Clark College, USA

Publications (selected)

  1. Carter, J., Magnuson, N.S., Davis, W.C., Mason, P.H., Magnuson, J.A., Tallmadge, J.E. and Barr, P.J. Development and maintenance of bovine cytotoxic lymphocytes with recombinant interleukin-2. Virology 57:123-129. 1986.
  2. Carter, J.J., Weinberg, A.D., Pollard, A., Reeves, R., Magnuson, J.A. and Magnuson, N.S. Inhibition of T-lymphocyte mitogenic responses and effects on cell functions by bovine herpesvirus 1. Journal of Virology 63:1525-1530. 1989.
  3. Carter, J.J., Yaegashi, N., Jenison, S.A. and Galloway, D.A. Expression of human papillomavirus proteins in yeast Saccharomyces cerevisiae. Virology 182:513-521. 1991.
  4. Carter, J.J., Hagensee, M., Taflin, M.C., Lee, S.K., Koutsky, L.A. and Galloway, D.A. HPV-1 capsids expressed in vitro detect human serum antibodies associated with foot warts. Virology 195:456-462. 1993.
  5. Carter, J.J., Hagensee, M.E., Lee, S.K., McKnight, B., Koutsky, L.A. and Galloway, D.A. Use of HPV-1 capsids produced by recombinant vaccinia viruses in an ELISA to detect serum antibodies in people with foot warts. Virology 199: 284-291. 1994.
  6. Hagensee, M.E., Carter, J.J., Wipf, G.P., and Galloway, D.A. Immunization of mice with HPV- vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies. Virology 206:174-182. 1995.
  7. Carter, J.J., Wipf, G., Hagensee, M.E., Taflin, M.C., McKnight, B., Habel, L.A., Lee, S.K., Kuypers, J., Kiviat, N. Daling, J.R., Koutsky, L.A., Watts, D.H., Holmes, K.K. and Galloway, D.A. Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts. Journal of Infectious Diseases 172(1): 11-18. 1995.
  8. Hagensee, M.E., Carter, J.J., Wipf, G.C. and Galloway, D.A. Serologic response in mice to vaccinia-virus produced HPV-1 capsids. Virology 206(1): 174-182. 1995.
  9. Daling, J.R., Madeleine, M.M., McKnight, B., Carter, J.C. Schwartz, S.M., Beckmann, A.M., Mandelson, M.T., Galloway, D.A. The relationship of human papillomavirus - related cervical tumors to cigarette smoking, oral contraceptive use and prior herpes simplex -2 infection. Cancer, Epidemiology, Biomarkers & Prevention 5:541-548. 1996
  10. Carter, J.J. Koutsky, L.A., Wipf, G.C., Christensen, N.D., Lee, S-K. Kuypers, J., Kiviat, N.B., Galloway, D.A. The natural history of HPV 16 capsid antibodies among a cohort of university women. J. Infectious Diseases 174(5): 927-936. 1996.
  11. Christensen, N.D., Dillner, J., Carter, J.J., Wipf, G.C., Reed, C.A., Cladel, N.M., Galloway, D.A. Surface conformational and linear epitopes on HPV 16 and HPV 18 virus-like particles as defined by monoclonal antibodies. Virology 223(1): 174-184. 1996.
  12. Madeleine, M.M., Daling, J.R., Schwartz, S.M., Carter, J.J., Wipf, G.C., McKnight, B., Kurman, R.J., Ashley, R., Beckmann, A.M., Sherman, K.J., Galloway, D.A. HSV2 and smoking: potential cofactors with HPV in a population-based study of vulvar cancer. Cancer Epidemiology, Biomarkers and Prevention. J. Nat. Cancer Inst. 89(20): 1516-1522. 1997.
  13. Carter, J.J., Galloway, D.A. Humoral Immune Response to Human Papillomavirus Infection. In: “Papillomaviruses: clinics in dermatology” Eds. S. Jablonska and G. Orth, Elsevier Science 15(2): 249-259. 1997.
  14. Schwartz S.M., Daling J.R., Doody D.R., Wipf G.C., Carter J.J., Madeleine M.M., Mao E.J., Fitzgibbons E.D., Huang S., Beckmann A.M., McDougall J.K., Galloway D.A.. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 90(21): 1626-1636. 1998.
  15. Carter J.J., Koutsky L.A., Hughes J.P., Lee S-K., Kuypers J., Kiviat N., Galloway D.A. Comparison of HPV 16, 18 and 6 capsid antibody responses following incident infection. Journal of Infectious Diseases. J. Infec. Dis. 181(6): 1911-1919. 2000.
  16. Madeleine M.M., Shera, K., Schwartz D.M., Daling J.R., Galloway D.A Wipf G.C., Carter J.J., McKnight, B., McDougall J.K.. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer. Cancer Epidemiology, Biomarkers & Prevention. 9(2): 225-227. 2000.
  17. Carter J.J., Madeleine M.M., Shera, K., Schwartz D.M., Cushing-Haugen, K,L., Wipf G.C., Porter P., Daling J.R., McDougall J.K., Galloway D.A.. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Research. 61:1934-1940. 2001.
  18. Madeleine M.M., Daling J.R., Schwartz D.M., Shera, K., McKnight, B., Carter J.J., Wipf G.C., Critchlow C.W., McDougall J.K., Porter P., Galloway D.A. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiology, Biomarkers & Prevention. 10(3): 171-177. 2001.
  19. Xi L.F., Carter J.J., Galloway D.A.., Kuypers J., Hughes, J.P., Lee, S.K., Adam, D.E., Kiviat, N.B., Koutsky L.A.. Acquisition and Natural History of Human Papillomavirus Type 16 Variant Infection among a Cohort of Female University Students. Cancer Epidemiology, Biomarkers & Prevention 11(4):343-51. 2002.
  20. Daling, J.R., Madeleine, M.M., Schwartz, S.M., Shera, K.A., Carter, J.J., McKnight, B., Porter, P.L., Galloway, D.A., McDougall J.K., Tamimi H. A Population-Based Study of Squamous Cell Vaginal Cancer: HPV and Cofactors Gynecol Oncol. 84: 263-270 2002.

Profile Details